Business Practice

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

AI is not just for the drug development phase of pharmaceutical manufacturing. Now is the time for the business side to leverage it.

New medicines save lives, but they take too long to get to market. Could AI make a difference?

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

What happens when freezers fail? Experts look at the lessons that can be learned from catastrophic power outages.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.

Why a forward-thinking approach is crucial for patient safety and industry success